A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

NCT00643760 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathy, Diabetic

Interventions

DRUG: Placebo
DRUG: GEn 1200mg/day
DRUG: GEn 2400mg/day
DRUG: GEn 3600mg/day
DRUG: Pregabalin

Sponsor

XenoPort, Inc.